AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27627596 — intervention group
Group type: COMPARATOR
Intervention: Control group (oral hygiene education only)
Number of subjects: 466
Study 26308827 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 seconds of interrepetition rest (IRR12)
Number of subjects: 34
Study 26308827 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 seconds of interrepetition rest (IRR6)
Number of subjects: 34
Study 26308827 — intervention group
Group type: COMPARATOR
Intervention: Continuous repetitions (CR)
Number of subjects: 34
Study 23362019 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon catheter
Number of subjects: 30
Study 23362019 — intervention group
Group type: COMPARATOR
Intervention: RF energy-based pulmonary vein ablation catheter (PVAC)
Number of subjects: 30
Study 23362019 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Cryoballoon and PVAC)
Number of subjects: 30
Study 21599573 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 ml of red wine/day for women (16 g ethanol/day) or 300 ml of red wine/day for men (33 g ethanol/day)
Number of subjects: 44
Study 21599573 — intervention group
Group type: COMPARATOR
Intervention: Alcohol abstention for 90 days
Number of subjects: 44
Study 18528650 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat/steam-generating sheet
Number of subjects: 37
Study 18528650 — intervention group
Group type: COMPARATOR
Intervention: Dry heat-generating sheet
Number of subjects: 37
Study 16766434 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens/medroxyprogesterone acetate (CE/MPA) doses: 0.625/2.5, 0.45/1.5, or 0.3/1.5 mg daily for 24 weeks
Number of subjects: 1028
Study 12959796 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive recruitment strategies (in-person appeals by study staff and health care providers)
Number of subjects: 600
Study 12959796 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive recruitment strategies (disseminating information that asked people to call a study hotline)
Number of subjects: 600
Study 12959796 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of recruitment
Number of subjects: 600
Study 10862930 — intervention group
Group type: EXPERIMENTAL
Intervention: Native /ba/‐/da/ contrasts
Number of subjects: 0
Study 10862930 — intervention group
Group type: EXPERIMENTAL
Intervention: Hindi dental /da/‐retroflex /da/ contrasts
Number of subjects: 0
Study 10862930 — intervention group
Group type: EXPERIMENTAL
Intervention: Within‐category /ba/‐/ba/ contrasts
Number of subjects: 0
Study 8904521 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) 300 U kg‐1, i.v. or s.c., once, combined with parenteral and oral iron
Number of subjects: 90
Study 8904521 — intervention group
Group type: COMPARATOR
Intervention: Iron therapy only
Number of subjects: 90
Study 2125737 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate (mean daily dose of 587 +/- 49 mg)
Number of subjects: 10
Study 6998597 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg of methylprednisolone sodium succinate (MPN)
Number of subjects: 28
Study 6998597 — intervention group
Group type: COMPARATOR
Intervention: 15 mg/kg of mannitol placebo (PL)
Number of subjects: 28
Study 31585794 — intervention group
Group type: EXPERIMENTAL
Intervention: Close Reading and Creative Writing program
Number of subjects: 49
Study 31585794 — intervention group
Group type: COMPARATOR
Intervention: Classical structured educational approach
Number of subjects: 49
Study 31056884 — intervention group
Group type: EXPERIMENTAL
Intervention: Shallow acupuncture combined with ear-acupoint pellet-pressing
Number of subjects: 60
Study 31056884 — intervention group
Group type: COMPARATOR
Intervention: Oral Alprazolam tablets once a day
Number of subjects: 60
Study 28356271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cashew diet (28-64 g/d)
Number of subjects: 51
Study 28356271 — intervention group
Group type: COMPARATOR
Intervention: Potato chips (control)
Number of subjects: 51
Study 25308927 — intervention group
Group type: EXPERIMENTAL
Intervention: TF+YF+MenACWY-CRM (group I)
Number of subjects: 301
Study 25308927 — intervention group
Group type: COMPARATOR
Intervention: TF+YF (group II)
Number of subjects: 301
Study 25308927 — intervention group
Group type: COMPARATOR
Intervention: MenACWY-CRM (group III)
Number of subjects: 301
Study 23911536 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose management
Number of subjects: 740
Study 23911536 — intervention group
Group type: COMPARATOR
Intervention: Standard glucose management
Number of subjects: 740
Study 21736808 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried plum (100 g/d)
Number of subjects: 160
Study 21736808 — intervention group
Group type: COMPARATOR
Intervention: Dried apple (comparative control)
Number of subjects: 160
Study 19402851 — intervention group
Group type: EXPERIMENTAL
Intervention: Short waiting time (WT) group (n = 174)
Number of subjects: 395
Study 19402851 — intervention group
Group type: COMPARATOR
Intervention: Nonfixed waiting time group (n = 221)
Number of subjects: 395
Study 16492822 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural block (CEB)
Number of subjects: 52
Study 16492822 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous popliteal nerve block (CPNB)
Number of subjects: 52
Study 16492822 — intervention group
Group type: COMPARATOR
Intervention: Both CEB and CPNB
Number of subjects: 52
Study 12723104 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum containing pyrophosphate (1%) and tripolyphosphate (1%)
Number of subjects: 117
Study 12723104 — intervention group
Group type: COMPARATOR
Intervention: No gum
Number of subjects: 117
Study 11054780 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 98
Study 9228589 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoms meeting Australian and ISO standards
Number of subjects: 92
Study 9228589 — intervention group
Group type: COMPARATOR
Intervention: Condoms meeting Swiss Quality Seal requirements
Number of subjects: 92
Study 7956622 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime insulin infusion (mean 1.5 +/- 0.1 IU/h)
Number of subjects: 20
Study 7956622 — intervention group
Group type: COMPARATOR
Intervention: Nocturnal insulin infusion (mean 1.5 +/- 0.1 IU/h)
Number of subjects: 20
Study 7956622 — intervention group
Group type: COMPARATOR
Intervention: Nocturnal insulin infusion
Number of subjects: 20
Study 7956622 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime insulin infusion
Number of subjects: 20
Study 3597264 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory resistive loads (8.9‐35.7 cmH2O X l‐1 X s)
Number of subjects: 0
Study 3597264 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no specific details provided)
Number of subjects: 0
Study 28738711 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo ward care (KWC)
Number of subjects: 79
Study 28738711 — intervention group
Group type: COMPARATOR
Intervention: Intermediate intensive care (IIC)
Number of subjects: 79
Study 27759857 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical squalamine and intravitreal ranibizumab 0.5 mg
Number of subjects: 20
Study 27759857 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg (control)
Number of subjects: 20
Study 25045235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine infusion during general anesthesia
Number of subjects: 40
Study 25045235 — intervention group
Group type: COMPARATOR
Intervention: Normal saline equivalent to ketamine infusions
Number of subjects: 40
Study 22513081 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine plus Lactobacillus johnsonii EM1 (Lj EM1)
Number of subjects: 63
Study 22513081 — intervention group
Group type: COMPARATOR
Intervention: Levocetirizine alone
Number of subjects: 63
Study 20930161 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin
Number of subjects: 119
Study 20930161 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 119
Study 18215561 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster seat promotion program in low-income community
Number of subjects: 0
Study 18215561 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster seat promotion program in Hispanic community
Number of subjects: 0
Study 18215561 — intervention group
Group type: COMPARATOR
Intervention: Comparison communities (control)
Number of subjects: 0
Study 16154441 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet (CHO, 58%; fat, 26%; n = 23)
Number of subjects: 47
Study 16154441 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid diet (high MUFA, CHO 45%; fat 40%; MUFA 22.5%; n = 24)
Number of subjects: 47
Study 16154441 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet (CHO)
Number of subjects: 47
Study 16154441 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid diet (high MUFA)
Number of subjects: 47
Study 15259481 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of 10 mg/kg triclabendazole
Number of subjects: 154
Study 15259481 — intervention group
Group type: COMPARATOR
Intervention: Single dose of 10 mg/kg triclabendazole
Number of subjects: 154
Study 10223765 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 0
Study 10223765 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0
Study 10223765 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined adjuvant chemotherapy and radiotherapy
Number of subjects: 0
Study 8964406 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 134
Study 8964406 — intervention group
Group type: COMPARATOR
Intervention: Endoscopy
Number of subjects: 134
Study 1403921 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mm access preparations wetted with mercury-rich amalgam before restoration
Number of subjects: 72
Study 1403921 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mm access preparations restored unwetted
Number of subjects: 72
Study 1403921 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 3886191 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone (1.5 mg/kg tid increasing to a maximum dosage of 200 mg tid)
Number of subjects: 99
Study 3886191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 3886191 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 99
Study 30053060 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Action Plan (AAP) with standard care
Number of subjects: 320
Study 30053060 — intervention group
Group type: COMPARATOR
Intervention: Routine standard of care (Control)
Number of subjects: 320
Study 26911981 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 127
Study 26911981 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine Injections (LI)
Number of subjects: 127
Study 26911981 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Physical Therapy and Lidocaine Injections (PT + LI)
Number of subjects: 127
Study 24468797 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic girdle
Number of subjects: 48
Study 24468797 — intervention group
Group type: COMPARATOR
Intervention: No girdle (Control)
Number of subjects: 48
Study 22629839 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamberin
Number of subjects: 89
Study 22629839 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 89
Study 20173440 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniscalpel-needle (MSN) release in conjunction with self neck-stretching exercises
Number of subjects: 43
Study 20173440 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture needling treatment and self neck-stretching exercises
Number of subjects: 43
Study 20173440 — intervention group
Group type: COMPARATOR
Intervention: Self neck-stretching exercises only
Number of subjects: 43
Study 20173440 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniscalpel-needle (MSN) release
Number of subjects: 43
Study 18243639 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous tetrodotoxin administered over Days 1-4
Number of subjects: 82
Study 18243639 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 82
Study 18243639 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous tetrodotoxin
Number of subjects: 82
Study 16012279 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS applied for 10 consecutive weekdays, for 15 minutes at 1 Hz and 90% of the resting motor threshold
Number of subjects: 33
Study 16012279 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 33
Study 12898503 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient commitment (OPC)
Number of subjects: 0
Study 10397520 — intervention group
Group type: EXPERIMENTAL
Intervention: One stage full-mouth disinfection treatment
Number of subjects: 40
Study 10397520 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (scaling and root planing per quadrant at 2-week intervals)
Number of subjects: 40
Study 8655981 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide (NO) treatment
Number of subjects: 35
Study 8655981 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 controls)
Number of subjects: 35
Study 8655981 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 35
Study 1515957 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) 6 micrograms.kg‐1.min‐1
Number of subjects: 37
Study 1515957 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (NICAR) 10 micrograms.kg‐1.min‐1 over 10 minutes followed by an infusion at 4 mg.kg‐1.min‐1
Number of subjects: 37
Study 7124431 — intervention group
Group type: EXPERIMENTAL
Intervention: Motipress (combined anxiolytic/antidepressant)
Number of subjects: 0
Study 7124431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31689640 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 324
Study 31689640 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI with a telephone booster (BMI + B)
Number of subjects: 324
Study 31689640 — intervention group
Group type: COMPARATOR
Intervention: Brief Advice (BA)
Number of subjects: 324
Study 28318407 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-mold room temperature vulcanizing silicone toe separator for 6 hours per night for 12 months
Number of subjects: 90
Study 28318407 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 90
Study 27476789 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg once per day (or 30 mg once per day for specific patients)
Number of subjects: 771
Study 27476789 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (dose adjusted to maintain INR between 2.0 and 3.0)
Number of subjects: 771
Study 27476789 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 771
Study 27476789 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 771
Study 25181622 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectally administrated 800 mg misoprostol
Number of subjects: 192
Study 25181622 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin infusion
Number of subjects: 192
Study 22248028 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐elemene at 45 mg/kg
Number of subjects: 0
Study 19693500 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense therapy (CEOP/IMVP-Dexa)
Number of subjects: 115
Study 19693500 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (CHOP)
Number of subjects: 115
Study 18584415 — intervention group
Group type: EXPERIMENTAL
Intervention: E(2) 2 mg/day plus medroxyprogesterone acetate (MPA) 2.5 mg/day
Number of subjects: 125
Study 18584415 — intervention group
Group type: COMPARATOR
Intervention: E(2) 2 mg/day
Number of subjects: 125
Study 18584415 — intervention group
Group type: EXPERIMENTAL
Intervention: E(2) 2 mg/day plus dienogest 2 mg/day
Number of subjects: 125
Study 18584415 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 125
Study 18584415 — intervention group
Group type: EXPERIMENTAL
Intervention: E(2) 2 mg/day plus norethisterone acetate (NETA) 1 mg/day
Number of subjects: 125
Study 16198422 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 37
Study 16198422 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 37
Study 12174408 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention strategy including direct letters to patients
Number of subjects: 29
Study 12174408 — intervention group
Group type: COMPARATOR
Intervention: Two interventions that did not include direct patient letters
Number of subjects: 29
Study 10206086 — intervention group
Group type: COMPARATOR
Intervention: Nisoldipine 5 mg alone
Number of subjects: 7
Study 10206086 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 5 mg with ketoconazole 200 mg (4 days pretreatment and concomitant administration)
Number of subjects: 7
Study 7842185 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (80 micrograms)
Number of subjects: 8
Study 7842185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2696323 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative doxorubicin
Number of subjects: 240
Study 2696323 — intervention group
Group type: COMPARATOR
Intervention: Control (no doxorubicin)
Number of subjects: 240
Study 2696323 — intervention group
Group type: EXPERIMENTAL
Intervention: Compartmental or wide amputation
Number of subjects: 240
Study 2696323 — intervention group
Group type: EXPERIMENTAL
Intervention: Compartmental local excision
Number of subjects: 240
Study 2696323 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide local excision
Number of subjects: 240
Study 2696323 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginal excision and radiotherapy
Number of subjects: 240
Study 2696323 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginal excision alone (reevaluated margin)
Number of subjects: 240
Study 31955164 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-gauge illumination-aided scleral buckling (SB) combined with hyaluronate injection after subretinal fluid drainage.
Number of subjects: 45
Study 31955164 — intervention group
Group type: COMPARATOR
Intervention: Conventional SB with binocular indirect ophthalmoscope combined with air injection.
Number of subjects: 45
Study 30865795 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (400 mg oral doxycycline and 400 mg oral metronidazole)
Number of subjects: 3412
Study 30865795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3412
Study 28338503 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalline valsartan/sacubitril (LCZ696) 400 mg daily
Number of subjects: 907
Study 28338503 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 320 mg daily
Number of subjects: 907
Study 28338503 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of free valsartan 320 mg and sacubitril 200 mg
Number of subjects: 907
Study 28338503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 907
Study 25464158 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxious conditioning stimulus (CS)
Number of subjects: 0
Study 25464158 — intervention group
Group type: COMPARATOR
Intervention: Non-noxious (sham) conditioning stimulus (CS)
Number of subjects: 0
Study 23871265 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (3mg/kg) administered intramuscularly for 3 days p.p.
Number of subjects: 20
Study 21282280 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine patch (9.5 mg/24 hours)
Number of subjects: 892
Study 21282280 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine capsules (6 mg twice daily)
Number of subjects: 892
Study 18463427 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic (0.1 g/kg b.w. daily for 1 month)
Number of subjects: 13
Study 16415635 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive therapy using fixed-dose combinations of two antihypertensive agents.
Number of subjects: 0
Study 16415635 — intervention group
Group type: COMPARATOR
Intervention: Standard antihypertensive therapy (implied control group).
Number of subjects: 0
Study 12679392 — intervention group
Group type: EXPERIMENTAL
Intervention: CBF SPECT with 3D fractal analysis (3D-FA) and 3D stereotactic surface projections (3D-SSP)
Number of subjects: 17
Study 12679392 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-SSP analysis
Number of subjects: 17
Study 12679392 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 17
Study 10919684 — intervention group
Group type: EXPERIMENTAL
Intervention: HFA 134a pMDI
Number of subjects: 412
Study 10919684 — intervention group
Group type: COMPARATOR
Intervention: CFC pMDI
Number of subjects: 412
Study 8904627 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg butorphanol nasal spray every 6 h
Number of subjects: 16
Study 8904627 — intervention group
Group type: COMPARATOR
Intervention: 300 mg cimetidine tablet every 6 h
Number of subjects: 16
Study 8904627 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of butorphanol nasal spray and cimetidine every 6 h
Number of subjects: 16
Study 1414906 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg SR verapamil with a standardized meal
Number of subjects: 9
Study 1414906 — intervention group
Group type: COMPARATOR
Intervention: 240 mg SR verapamil on an empty stomach
Number of subjects: 9
Study 1414906 — intervention group
Group type: COMPARATOR
Intervention: 10 mg intravenous verapamil
Number of subjects: 9
Study 4064556 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear visual analogue scaling
Number of subjects: 0
Study 4064556 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio magnitude estimation
Number of subjects: 0
Study 31680077 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% FV diet
Number of subjects: 30
Study 31680077 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% FV diet
Number of subjects: 30
Study 31680077 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 30
Study 30137647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 400 IU/day
Number of subjects: 194